Cargando…
P1531: TIXAGEVIMAB-CILGAVIMAB THERAPY IN THE PREVENTION OF SARS-COV2 INFECTION IN NON-HODGKIN-B LYMPHOMAS AND HODGKIN LYMPHOMAS UNDER TREATMENT: OUR EXPERIENCE
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429923/ http://dx.doi.org/10.1097/01.HS9.0000973000.81676.fe |
| _version_ | 1785090832220553216 |
|---|---|
| author | Pezzullo, Luca Giudice, Valentina D’addona, Matteo Buonanno, Maria Teresa Novellis, Danilo DE Ferrara, Idalucia Fontana, Raffaele Guariglia, Roberto Luponio, Serena Martorelli, Maria Carmela Mettivier, Laura Serio, Bianca Selleri, Carmine |
| author_facet | Pezzullo, Luca Giudice, Valentina D’addona, Matteo Buonanno, Maria Teresa Novellis, Danilo DE Ferrara, Idalucia Fontana, Raffaele Guariglia, Roberto Luponio, Serena Martorelli, Maria Carmela Mettivier, Laura Serio, Bianca Selleri, Carmine |
| author_sort | Pezzullo, Luca |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10429923 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104299232023-08-17 P1531: TIXAGEVIMAB-CILGAVIMAB THERAPY IN THE PREVENTION OF SARS-COV2 INFECTION IN NON-HODGKIN-B LYMPHOMAS AND HODGKIN LYMPHOMAS UNDER TREATMENT: OUR EXPERIENCE Pezzullo, Luca Giudice, Valentina D’addona, Matteo Buonanno, Maria Teresa Novellis, Danilo DE Ferrara, Idalucia Fontana, Raffaele Guariglia, Roberto Luponio, Serena Martorelli, Maria Carmela Mettivier, Laura Serio, Bianca Selleri, Carmine Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429923/ http://dx.doi.org/10.1097/01.HS9.0000973000.81676.fe Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Pezzullo, Luca Giudice, Valentina D’addona, Matteo Buonanno, Maria Teresa Novellis, Danilo DE Ferrara, Idalucia Fontana, Raffaele Guariglia, Roberto Luponio, Serena Martorelli, Maria Carmela Mettivier, Laura Serio, Bianca Selleri, Carmine P1531: TIXAGEVIMAB-CILGAVIMAB THERAPY IN THE PREVENTION OF SARS-COV2 INFECTION IN NON-HODGKIN-B LYMPHOMAS AND HODGKIN LYMPHOMAS UNDER TREATMENT: OUR EXPERIENCE |
| title | P1531: TIXAGEVIMAB-CILGAVIMAB THERAPY IN THE PREVENTION OF SARS-COV2 INFECTION IN NON-HODGKIN-B LYMPHOMAS AND HODGKIN LYMPHOMAS UNDER TREATMENT: OUR EXPERIENCE |
| title_full | P1531: TIXAGEVIMAB-CILGAVIMAB THERAPY IN THE PREVENTION OF SARS-COV2 INFECTION IN NON-HODGKIN-B LYMPHOMAS AND HODGKIN LYMPHOMAS UNDER TREATMENT: OUR EXPERIENCE |
| title_fullStr | P1531: TIXAGEVIMAB-CILGAVIMAB THERAPY IN THE PREVENTION OF SARS-COV2 INFECTION IN NON-HODGKIN-B LYMPHOMAS AND HODGKIN LYMPHOMAS UNDER TREATMENT: OUR EXPERIENCE |
| title_full_unstemmed | P1531: TIXAGEVIMAB-CILGAVIMAB THERAPY IN THE PREVENTION OF SARS-COV2 INFECTION IN NON-HODGKIN-B LYMPHOMAS AND HODGKIN LYMPHOMAS UNDER TREATMENT: OUR EXPERIENCE |
| title_short | P1531: TIXAGEVIMAB-CILGAVIMAB THERAPY IN THE PREVENTION OF SARS-COV2 INFECTION IN NON-HODGKIN-B LYMPHOMAS AND HODGKIN LYMPHOMAS UNDER TREATMENT: OUR EXPERIENCE |
| title_sort | p1531: tixagevimab-cilgavimab therapy in the prevention of sars-cov2 infection in non-hodgkin-b lymphomas and hodgkin lymphomas under treatment: our experience |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429923/ http://dx.doi.org/10.1097/01.HS9.0000973000.81676.fe |
| work_keys_str_mv | AT pezzulloluca p1531tixagevimabcilgavimabtherapyinthepreventionofsarscov2infectioninnonhodgkinblymphomasandhodgkinlymphomasundertreatmentourexperience AT giudicevalentina p1531tixagevimabcilgavimabtherapyinthepreventionofsarscov2infectioninnonhodgkinblymphomasandhodgkinlymphomasundertreatmentourexperience AT daddonamatteo p1531tixagevimabcilgavimabtherapyinthepreventionofsarscov2infectioninnonhodgkinblymphomasandhodgkinlymphomasundertreatmentourexperience AT buonannomariateresa p1531tixagevimabcilgavimabtherapyinthepreventionofsarscov2infectioninnonhodgkinblymphomasandhodgkinlymphomasundertreatmentourexperience AT novellisdanilode p1531tixagevimabcilgavimabtherapyinthepreventionofsarscov2infectioninnonhodgkinblymphomasandhodgkinlymphomasundertreatmentourexperience AT ferraraidalucia p1531tixagevimabcilgavimabtherapyinthepreventionofsarscov2infectioninnonhodgkinblymphomasandhodgkinlymphomasundertreatmentourexperience AT fontanaraffaele p1531tixagevimabcilgavimabtherapyinthepreventionofsarscov2infectioninnonhodgkinblymphomasandhodgkinlymphomasundertreatmentourexperience AT guarigliaroberto p1531tixagevimabcilgavimabtherapyinthepreventionofsarscov2infectioninnonhodgkinblymphomasandhodgkinlymphomasundertreatmentourexperience AT luponioserena p1531tixagevimabcilgavimabtherapyinthepreventionofsarscov2infectioninnonhodgkinblymphomasandhodgkinlymphomasundertreatmentourexperience AT martorellimariacarmela p1531tixagevimabcilgavimabtherapyinthepreventionofsarscov2infectioninnonhodgkinblymphomasandhodgkinlymphomasundertreatmentourexperience AT mettivierlaura p1531tixagevimabcilgavimabtherapyinthepreventionofsarscov2infectioninnonhodgkinblymphomasandhodgkinlymphomasundertreatmentourexperience AT seriobianca p1531tixagevimabcilgavimabtherapyinthepreventionofsarscov2infectioninnonhodgkinblymphomasandhodgkinlymphomasundertreatmentourexperience AT sellericarmine p1531tixagevimabcilgavimabtherapyinthepreventionofsarscov2infectioninnonhodgkinblymphomasandhodgkinlymphomasundertreatmentourexperience |